A recent study highlights methotrexate-induced myelopathy as a significant mimic of relapsed malignant lymphoma, complicating diagnosis. This discovery emphasizes the need for careful evaluation in patients undergoing methotrexate treatment.
methotrexate induced myelopathy a great imitator of relapsed malignant lymphoma
Original title: “Methotrexate-induced myelopathy: a great imitator of relapsed malignant lymphoma.”